Results

1–10 of 65 results for Anti-VEGF Agents

Interview Reversal of Retinal Ischemia After Anti-VEGF Therapy
Thomas R. Friberg, MD
Updates from the Field
2019
Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD
Tarek S. Hassan, MD
Updates from the Field
2019
Predictors of Post-injection Endophthalmitis: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength
Tarek S. Hassan, MD
Updates from the Field
2019
The Functional Impact of Fluctuating Retinal Thickness in the IVAN and CATT Trials: A Meta-Analysis
Usha Chakravarthy
Updates from the Field
2019
BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Updates from the Field
2019
Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved Diabetic Macular Edema
Carl W. Baker, MD
Updates from the Field
2019
Vision Threatening Complications in Patients With Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials
Diana V Do, MD
Updates from the Field
2019
LEAVO vs. SCORE2: A Comparison of Two CRVO Comparative-Effectiveness Trials for the Treatment of Macular Edema With Anti-VEGF Agents
Barbara A. Blodi, MD
Updates from the Field
2019
Episode 29: Anti-VEGF Levels in Breast Milk after Intravitreal Injections- Drs. Muni and Juncal
Keyvan Koushan, MD, FRCSC
Member Podcasts
Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization
Jeffrey L. Olson, MD
Annual Meeting Talks
2019